OFS Capital Announces $69 Million Offering of 7.50% Notes Due 2028
OFS Capital launches $69M offering of 7.50% notes due 2028 to strengthen liquidity and support growth. #OFSCapital #DebtOffering
Insights Team
OFS Capital to Redeem $69 Million of 4.75% Notes Due 2026 in August
OFS Capital plans to redeem $69M of 4.75% notes due 2026, strengthening its balance sheet and optimizing capital structure. #OFSCapital #DebtRedemption
Galaxy Gaming Merger Deadline with Evolution Extended to October 18
Galaxy Gaming and Evolution extend merger deadline to October 18, advancing strategic consolidation in the gaming industry. #GalaxyGaming #EvolutionMerger
Coca-Cola Europacific Partners Advances Share Buyback Program with Latest Repurchases
Coca-Cola Europacific Partners accelerates share buyback, repurchasing shares to enhance shareholder value. #CocaColaEuropacific #ShareBuyback
Miami International Launches $100 Million US IPO Effort
Miami International initiates $100M IPO to expand market presence and enhance trading platform capabilities. #MiamiInternational #IPO
NorthAnn Regains NYSE American Compliance After Filing Delayed Quarterly Report
NorthAnn restores NYSE American compliance by filing delayed quarterly report, stabilizing investor confidence. #NorthAnn #NYSECompliance
Imunon Registers Additional $4.5 Million in Shares Under At-The-Market Program
Imunon expands ATM program by $4.5M to support clinical development and operational growth. #Imunon #ATMProgram
TruGolf Holdings Exchanges Convertible Notes for Preferred Stock and Amends Warrant Terms
TruGolf Holdings restructures debt by exchanging convertible notes for preferred stock and revises warrant terms to strengthen financial position. #TruGolfHoldings #FinancialRestructuring
Lion Group Holding Completes $3 Million Convertible Note Offering
Lion Group Holding successfully closes $3M convertible note offering to support growth and operational expansion. #LionGroupHolding #ConvertibleNotes
Connect Biopharma Appoints James A. Schoeneck to Board of Directors
Connect Biopharma strengthens leadership with James A. Schoeneck joining its board, enhancing strategic growth and governance. #ConnectBiopharma #Leadership